Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sorrento Therapeutics
Sort By
Newest First
1 / 1
1 / 1
COVID-19 Vaccine
STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection in Preclinical Studies
Sorrento Therapeutics, Inc.
PR-M05-20-NI-028
May 18, 2020
